Zünd is showing how it combines intelligent cutting systems and software to boost productive composites environments.

Review Article Published: November 2009 The bladder extracellular matrix. Part I: architecture, development and disease Karen J. Aitken & Darius J. Bägli Nature Reviews Urology 6, 596–611 (2009 ...

NAFILean materials family blends low-carbon recycled plastics and renewable post-consumer sources to provide a sustainable, ...

LOS ANGELES, CA– In a groundbreaking achievement set to reshape the future of transplant medicine, Dr. Inderbir S. Gill has led the world’s first successful bladder transplant in a human being ...

AstraZeneca AZN announced that the European Commission has approved its blockbuster cancer drug, Imfinzi (durvalumab), for a ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales expectations for the drug, even though it recently failed a second ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from ...